Quantcast

Elsevier Integrates New Collaboration Analysis Capabilities Into SciVal Strata to Further Enhance Research Evaluation

July 12, 2011

AMSTERDAM, July 12, 2011 /PRNewswire/ –

Elsevier, a world-leading provider of scientific, technical and medical
information products and services, today announced two new collaboration
analyses capabilities available within SciVal Strata (
http://www.info.scival.com/strata), a web-based tool focused on the
evaluation of research performance. SciVal Strata offers researchers and
research administrators the flexibility to construct relevant contextual
data to benchmark research teams or individual researchers, using a range of
indicators based on Elsevier’s Scopus data.

The collaboration analysis capabilities add a novel dimension to SciVal
Strata, enabling users to assess collaboration between researchers. The new
capabilities are:

        - Geographical Collaboration Network: Enables research
          administrators and researchers to view the locations by region and
          country where a researcher or research team is or has collaborative
          links. Furthermore, it allows users to observe activity trends over time
          for any specific region or country.
        - Author Network: Allows users to view the complete team in which
          researchers or research teams collaborated. Moreover, it indicates how
          often those co-authors have published with that individual or team
          displaying their prestige according to the h- or g-Indices, measures
          that represent a combination of productivity and citation impact.

“By empowering academic and governmental research advisors and
researchers to assess collaboration, SciVal Strata now provides a
multidimensional way to evaluate distinguished researchers and early career
researchers alike,” said Niels Weertman, Vice President of Product
Management, Scopus and SciVal. “Furthermore, this new approach will support
strategic decisions including recruitment and partnerships, ultimately
improving research outcomes.”

For an early career researcher who has published few articles and has
not yet gained a critical mass of citation counts (an indicator for
traditional performance analysis), geographical collaboration and
prestigious co-authors may indicate that the researcher is viewed positively
in the field and able to attract established scientists for collaboration -
all qualifications for potential recruitment or funding applications. By
providing this novel approach to evaluating research performance, SciVal
Strata continues to enable researchers and research administrators to
identify the strengths of research teams and individual researchers most
relevant to their field of expertise, topics of interest or career stage.

About the Elsevier SciVal(R) Suite

Elsevier’s SciVal suite [http://www.info.scival.com ] (
http://www.info.scival.com) of services supports academic and government
leadership in evaluating, establishing and executing research strategies
that optimize the performance of existing assets and maximize investments to
enhance near and long-term productivity. SciVal tools leverage Scopus(R)
data, Elsevier’s trusted source of bibliometric data, to offer innovative
yet authoritative solutions. Current suite offerings include: SciVal
Spotlight(TM), a strategic tool that generates unique institutional and
country maps of existing and emerging strengths based on an
interdisciplinary perspective of current performance; SciVal Funding(TM), an
online solution that provides targeted recommendations on grants to pursue
based on pre-populated research profiles and historical awards; SciVal
Strata, a web-based research performance tool that offers users the
flexibility to construct relevant contextual data to evaluate research teams
or individual researchers, using a range of indicators based on Scopus data;
SciVal Experts, a semantic technology-based application that enables
researchers to identify and locate sources of expertise at an individual or
departmental level within and across institutions.

About Elsevier

Elsevier is a world-leading provider of scientific, technical and
medical information products and services. The company works in partnership
with the global science and health communities to publish more than 2,000
journals, including The Lancet [http://www.thelancet.com ] and Cell
[http://www.cell.com ], and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier’s online solutions include
SciVerse ScienceDirect [http://www.sciencedirect.com ], SciVerse Scopus
[http://www.scopus.nl ], Reaxys [http://www.reaxys.com ], MD Consult
[http://www.mdconsult.com ] and Nursing Consult
[http://www.nursingconsult.com ], which enhance the productivity of science
and health professionals, and the SciVal suite [http://www.scival.com ] and
MEDai’s Pinpoint Review [http://www.medai.com ], which help research and

health care institutions deliver better outcomes more cost-effectively. A
employs 7,000 people worldwide. The company is part of Reed Elsevier Group
PLC [http://www.reedelsevier.com ], a world-leading publisher and information
provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV.
The ticker symbols are REN (Euronext Amsterdam), REL (London Stock
Exchange), RUK and ENL (New York Stock Exchange).

        Media contact
        Jen Saunders/Sandra Plasse
        +1-212-752-8338
        jsaunders@psbpr.com
        splasse@psbpr.com

SOURCE Elsevier


Source: newswire



comments powered by Disqus